|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
17 October 2012 |
|
Main ID: |
NCT00386204 |
|
Date of registration:
|
10/10/2006 |
|
Primary sponsor: |
|
|
Public title:
|
Side Effects of Q-Switched Ruby Laser for the Treatment of Lentigines in Light and Dark Skin Types
|
|
Scientific title:
|
Efficacy and Side Effects of Q-Switched Ruby Laser Treatment of Solar Lentigines in Two Different Fitzpatrick Skin Types II and IV |
|
Date of first enrolment:
|
November 2005 |
|
Target sample size:
|
90 |
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT00386204 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind, Primary Purpose: Treatment
|
|
|
Countries of recruitment
|
|
Iran, Islamic Republic of
| | | | | | | |
|
Contacts
|
|
Name:
|
Parviz Toossi, M.D. |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Shaheed Beheshti Medical University |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Solar Lentigines
- Fitzpatrick skin type II and IV
Exclusion Criteria:
- Pregnancy
- Age above 80
- Photosensitivity
- Concern for malignancy
- Active Infection
Age minimum:
N/A
Age maximum:
80 Years
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Solar Lentigines
|
|
Intervention(s)
|
|
Device: Q-switched Ruby Laser
|
|
Primary Outcome(s)
|
|
Clinical Clearance
|
|
Side Effects
|
|
Secondary ID(s)
|
|
src-pts-11073
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|